

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | negative regulation of fibrinolysis (GO:0051918) | 6.79522516 |
| 2 | very-low-density lipoprotein particle assembly (GO:0034379) | 6.40738120 |
| 3 | regulation of fibrinolysis (GO:0051917) | 6.14165062 |
| 4 | plasma lipoprotein particle assembly (GO:0034377) | 5.79973400 |
| 5 | regulation of protein activation cascade (GO:2000257) | 5.79350353 |
| 6 | regulation of complement activation (GO:0030449) | 5.67992071 |
| 7 | low-density lipoprotein particle remodeling (GO:0034374) | 5.60513530 |
| 8 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 5.57779054 |
| 9 | protein carboxylation (GO:0018214) | 5.53863719 |
| 10 | peptidyl-glutamic acid carboxylation (GO:0017187) | 5.53863719 |
| 11 | intestinal cholesterol absorption (GO:0030299) | 5.43408131 |
| 12 | synaptic vesicle docking involved in exocytosis (GO:0016081) | 5.27386489 |
| 13 | protein-lipid complex assembly (GO:0065005) | 5.26971062 |
| 14 | synaptic vesicle maturation (GO:0016188) | 5.26142277 |
| 15 | L-phenylalanine catabolic process (GO:0006559) | 5.14924662 |
| 16 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 5.14924662 |
| 17 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 5.13868912 |
| 18 | synaptic vesicle exocytosis (GO:0016079) | 5.01775746 |
| 19 | glutamate secretion (GO:0014047) | 5.01562007 |
| 20 | cholesterol efflux (GO:0033344) | 4.98805034 |
| 21 | blood coagulation, intrinsic pathway (GO:0007597) | 4.95023000 |
| 22 | plasma lipoprotein particle remodeling (GO:0034369) | 4.86470043 |
| 23 | protein-lipid complex remodeling (GO:0034368) | 4.86470043 |
| 24 | macromolecular complex remodeling (GO:0034367) | 4.86470043 |
| 25 | locomotory exploration behavior (GO:0035641) | 4.83774846 |
| 26 | regulation of apoptotic cell clearance (GO:2000425) | 4.81006294 |
| 27 | regulation of cholesterol esterification (GO:0010872) | 4.79119327 |
| 28 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 4.78788564 |
| 29 | L-phenylalanine metabolic process (GO:0006558) | 4.78788564 |
| 30 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 4.75104192 |
| 31 | vocalization behavior (GO:0071625) | 4.70187082 |
| 32 | neurotransmitter-gated ion channel clustering (GO:0072578) | 4.57233311 |
| 33 | plasma lipoprotein particle organization (GO:0071827) | 4.47574302 |
| 34 | regulation of glutamate receptor signaling pathway (GO:1900449) | 4.45416750 |
| 35 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 4.36353958 |
| 36 | regulation of synaptic vesicle exocytosis (GO:2000300) | 4.35578138 |
| 37 | neurotransmitter secretion (GO:0007269) | 4.31317588 |
| 38 | protein-lipid complex subunit organization (GO:0071825) | 4.26688123 |
| 39 | high-density lipoprotein particle remodeling (GO:0034375) | 4.25843347 |
| 40 | negative regulation of protein activation cascade (GO:2000258) | 4.23409266 |
| 41 | regulation of N-methyl-D-aspartate selective glutamate receptor activity (GO:2000310) | 4.13026586 |
| 42 | positive regulation of dendritic spine morphogenesis (GO:0061003) | 4.11222475 |
| 43 | reverse cholesterol transport (GO:0043691) | 4.06117845 |
| 44 | regulation of long-term neuronal synaptic plasticity (GO:0048169) | 4.04292457 |
| 45 | regulation of synapse structural plasticity (GO:0051823) | 4.00728355 |
| 46 | complement activation, alternative pathway (GO:0006957) | 3.97853956 |
| 47 | regulation of plasminogen activation (GO:0010755) | 3.96841567 |
| 48 | plasma lipoprotein particle clearance (GO:0034381) | 3.96426515 |
| 49 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 3.96304022 |
| 50 | negative regulation of cholesterol transport (GO:0032375) | 3.95248208 |
| 51 | negative regulation of sterol transport (GO:0032372) | 3.95248208 |
| 52 | protein localization to synapse (GO:0035418) | 3.94840645 |
| 53 | positive regulation of membrane potential (GO:0045838) | 3.94527600 |
| 54 | regulation of bile acid biosynthetic process (GO:0070857) | 3.94356152 |
| 55 | triglyceride-rich lipoprotein particle remodeling (GO:0034370) | 3.93987095 |
| 56 | regulation of synaptic vesicle transport (GO:1902803) | 3.93896088 |
| 57 | regulation of cholesterol homeostasis (GO:2000188) | 3.90490729 |
| 58 | neuronal action potential propagation (GO:0019227) | 3.85454798 |
| 59 | cellular potassium ion homeostasis (GO:0030007) | 3.83950441 |
| 60 | regulation of neuronal synaptic plasticity (GO:0048168) | 3.80829496 |
| 61 | G-protein coupled glutamate receptor signaling pathway (GO:0007216) | 3.79192818 |
| 62 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 3.78992510 |
| 63 | glutamate receptor signaling pathway (GO:0007215) | 3.74365171 |
| 64 | synaptic transmission, glutamatergic (GO:0035249) | 3.71101194 |
| 65 | positive regulation of synaptic transmission, glutamatergic (GO:0051968) | 3.69666532 |
| 66 | regulation of excitatory postsynaptic membrane potential (GO:0060079) | 3.68416082 |
| 67 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.67779855 |
| 68 | response to histamine (GO:0034776) | 3.66405534 |
| 69 | gamma-aminobutyric acid transport (GO:0015812) | 3.62578253 |
| 70 | neuron-neuron synaptic transmission (GO:0007270) | 3.59164584 |
| 71 | sodium ion export (GO:0071436) | 3.58391459 |
| 72 | long-term memory (GO:0007616) | 3.58384766 |
| 73 | neurotransmitter transport (GO:0006836) | 3.54133960 |
| 74 | C4-dicarboxylate transport (GO:0015740) | 3.53504959 |
| 75 | negative regulation of complement activation (GO:0045916) | 3.52016925 |
| 76 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 3.50963820 |
| 77 | intestinal absorption (GO:0050892) | 3.50650381 |
| 78 | regulation of postsynaptic membrane potential (GO:0060078) | 3.50060146 |
| 79 | positive regulation of neurotransmitter secretion (GO:0001956) | 3.49188194 |
| 80 | regulation of cholesterol biosynthetic process (GO:0045540) | 3.45573730 |
| 81 | axon ensheathment in central nervous system (GO:0032291) | 3.44307425 |
| 82 | central nervous system myelination (GO:0022010) | 3.44307425 |
| 83 | positive regulation of neurotransmitter transport (GO:0051590) | 3.42322522 |
| 84 | gamma-aminobutyric acid signaling pathway (GO:0007214) | 3.41785021 |
| 85 | embryonic retina morphogenesis in camera-type eye (GO:0060059) | 3.41753210 |
| 86 | prepulse inhibition (GO:0060134) | 3.37523140 |
| 87 | exploration behavior (GO:0035640) | 3.36388870 |
| 88 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.36209301 |
| 89 | negative regulation of sodium ion transport (GO:0010766) | 3.35354333 |
| 90 | regulation of synaptic transmission, glutamatergic (GO:0051966) | 3.33370381 |
| 91 | long-term synaptic potentiation (GO:0060291) | 3.33355633 |
| 92 | regulation of neurotransmitter levels (GO:0001505) | 3.31258679 |
| 93 | negative regulation of dendrite morphogenesis (GO:0050774) | 3.27164522 |
| 94 | diacylglycerol metabolic process (GO:0046339) | 3.26808992 |
| 95 | cerebellar Purkinje cell differentiation (GO:0021702) | 3.25766833 |
| 96 | regulation of systemic arterial blood pressure by renin-angiotensin (GO:0003081) | 3.23030055 |
| 97 | membrane hyperpolarization (GO:0060081) | 3.21817840 |
| 98 | neuromuscular process controlling posture (GO:0050884) | 3.20507476 |
| 99 | regulation of voltage-gated calcium channel activity (GO:1901385) | 3.20149313 |
| 100 | positive regulation of hemostasis (GO:1900048) | 3.19587019 |
| 101 | positive regulation of blood coagulation (GO:0030194) | 3.19587019 |
| 102 | positive regulation of steroid metabolic process (GO:0045940) | 3.18453226 |
| 103 | striatum development (GO:0021756) | 3.15015513 |
| 104 | regulation of humoral immune response (GO:0002920) | 3.14567482 |
| 105 | postsynaptic membrane organization (GO:0001941) | 3.14146707 |
| 106 | positive regulation of synapse maturation (GO:0090129) | 3.13406545 |
| 107 | regulation of synapse maturation (GO:0090128) | 3.12636303 |
| 108 | regulation of synaptic plasticity (GO:0048167) | 3.12411288 |
| 109 | fibrinolysis (GO:0042730) | 3.11968615 |
| 110 | neuron cell-cell adhesion (GO:0007158) | 3.11957620 |
| 111 | behavioral response to cocaine (GO:0048148) | 3.09667296 |
| 112 | protein activation cascade (GO:0072376) | 3.09069027 |
| 113 | acute-phase response (GO:0006953) | 3.08779744 |
| 114 | regulation of neurotransmitter secretion (GO:0046928) | 3.08074948 |
| 115 | positive regulation of extracellular matrix organization (GO:1903055) | 3.07481628 |
| 116 | sterol transport (GO:0015918) | 3.06225155 |
| 117 | cholesterol transport (GO:0030301) | 3.06225155 |
| 118 | cerebellar granule cell differentiation (GO:0021707) | 3.06112445 |
| 119 | lipoprotein metabolic process (GO:0042157) | 3.03211194 |
| 120 | ethanol oxidation (GO:0006069) | 3.00323949 |
| 121 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.99906054 |
| 122 | positive regulation of synaptic transmission, GABAergic (GO:0032230) | 2.99384537 |
| 123 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.98894011 |
| 124 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.98894011 |
| 125 | triglyceride homeostasis (GO:0070328) | 2.98500350 |
| 126 | acylglycerol homeostasis (GO:0055090) | 2.98500350 |
| 127 | auditory behavior (GO:0031223) | 2.98169978 |
| 128 | lung epithelium development (GO:0060428) | 2.97947043 |
| 129 | activation of protein kinase A activity (GO:0034199) | 2.97365921 |
| 130 | cholesterol homeostasis (GO:0042632) | 2.95366521 |
| 131 | negative regulation of blood coagulation (GO:0030195) | 2.95306193 |
| 132 | negative regulation of hemostasis (GO:1900047) | 2.95306193 |
| 133 | regulation of neurotransmitter transport (GO:0051588) | 2.95291639 |
| 134 | positive regulation of respiratory burst (GO:0060267) | 2.94559964 |
| 135 | layer formation in cerebral cortex (GO:0021819) | 2.94044553 |
| 136 | sterol homeostasis (GO:0055092) | 2.92121635 |
| 137 | positive regulation of coagulation (GO:0050820) | 2.91967578 |
| 138 | phospholipid efflux (GO:0033700) | 2.91649713 |
| 139 | low-density lipoprotein particle clearance (GO:0034383) | 2.91162104 |
| 140 | visual learning (GO:0008542) | 2.89890275 |
| 141 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.89751078 |
| 142 | synaptic vesicle endocytosis (GO:0048488) | 2.89471886 |
| 143 | definitive hemopoiesis (GO:0060216) | 2.88903149 |
| 144 | sodium ion homeostasis (GO:0055078) | 2.88856502 |
| 145 | proline metabolic process (GO:0006560) | 2.88786742 |
| 146 | positive regulation of synaptic transmission, dopaminergic (GO:0032226) | 2.87761389 |
| 147 | cell communication by electrical coupling (GO:0010644) | 2.86778960 |
| 148 | drinking behavior (GO:0042756) | 2.86084129 |
| 149 | aromatic amino acid family catabolic process (GO:0009074) | 2.83383348 |
| 150 | mechanosensory behavior (GO:0007638) | 2.83181295 |
| 151 | membrane depolarization (GO:0051899) | 2.82838725 |
| 152 | regulation of vesicle fusion (GO:0031338) | 2.80586924 |
| 153 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.79680169 |
| 154 | positive regulation of synaptic transmission (GO:0050806) | 2.77665905 |
| 155 | presynaptic membrane assembly (GO:0097105) | 2.76562507 |
| 156 | learning (GO:0007612) | 2.76489617 |
| 157 | dicarboxylic acid biosynthetic process (GO:0043650) | 2.73945840 |
| 158 | dendritic spine morphogenesis (GO:0060997) | 2.73887233 |
| 159 | visual behavior (GO:0007632) | 2.73055374 |
| 160 | cellular sodium ion homeostasis (GO:0006883) | 2.72262162 |
| 161 | long term synaptic depression (GO:0060292) | 2.71009736 |
| 162 | regulation of female receptivity (GO:0045924) | 2.67558360 |
| 163 | potassium ion homeostasis (GO:0055075) | 2.66586322 |
| 164 | glutamate metabolic process (GO:0006536) | 2.65690812 |
| 165 | retinal rod cell development (GO:0046548) | 2.65281010 |
| 166 | membrane depolarization during action potential (GO:0086010) | 2.65054876 |
| 167 | behavioral defense response (GO:0002209) | 2.64375723 |
| 168 | behavioral fear response (GO:0001662) | 2.64375723 |
| 169 | synaptic transmission (GO:0007268) | 2.64019321 |
| 170 | negative regulation of synaptic transmission, glutamatergic (GO:0051967) | 2.63575404 |
| 171 | response to auditory stimulus (GO:0010996) | 2.62729518 |
| 172 | proline transport (GO:0015824) | 2.61289803 |
| 173 | negative regulation of synaptic transmission, GABAergic (GO:0032229) | 2.61068252 |
| 174 | positive regulation of dendritic spine development (GO:0060999) | 2.59586900 |
| 175 | relaxation of smooth muscle (GO:0044557) | 2.59117449 |
| 176 | negative regulation of dendrite development (GO:2000171) | 2.58554278 |
| 177 | transmission of nerve impulse (GO:0019226) | 2.58135308 |
| 178 | neuromuscular process controlling balance (GO:0050885) | 2.57518877 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 4.29897220 |
| 2 | * FOXA2_19822575_ChIP-Seq_HepG2_Human | 3.62633757 |
| 3 | * GBX2_23144817_ChIP-Seq_PC3_Human | 3.36567757 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.78514193 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.75718826 |
| 6 | * PPARA_22158963_ChIP-Seq_LIVER_Mouse | 2.73887768 |
| 7 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.66250341 |
| 8 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.59965534 |
| 9 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 2.57425180 |
| 10 | HOXA2_22223247_ChIP-Seq_E11.5_EMBRYO_Mouse | 2.48503051 |
| 11 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.36481990 |
| 12 | REST_21632747_ChIP-Seq_MESCs_Mouse | 2.34497426 |
| 13 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.33934302 |
| 14 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.32853356 |
| 15 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.28869136 |
| 16 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.28869136 |
| 17 | * HNF4A_19822575_ChIP-Seq_HepG2_Human | 2.28357147 |
| 18 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.21924105 |
| 19 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.18191897 |
| 20 | SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.09142307 |
| 21 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 2.07626008 |
| 22 | SCL_19346495_ChIP-Seq_HPC-7_Human | 2.02507422 |
| 23 | TAF15_26573619_Chip-Seq_HEK293_Human | 2.00278538 |
| 24 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 1.98524452 |
| 25 | IKZF1_21737484_ChIP-ChIP_HCT116_Human | 1.98258495 |
| 26 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.97967795 |
| 27 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.94008355 |
| 28 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.85248275 |
| 29 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.80560459 |
| 30 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.80280420 |
| 31 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.79413168 |
| 32 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 1.77509587 |
| 33 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.77165825 |
| 34 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.75975335 |
| 35 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.75878231 |
| 36 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.74886800 |
| 37 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.71814100 |
| 38 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.68092781 |
| 39 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.63428481 |
| 40 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 1.61742969 |
| 41 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 1.61541718 |
| 42 | TCF4_18268006_ChIP-ChIP_LS174T_Human | 1.61124597 |
| 43 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.53742180 |
| 44 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.52084196 |
| 45 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 1.49833460 |
| 46 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.47574883 |
| 47 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.46027444 |
| 48 | ZNF263_19887448_ChIP-Seq_K562_Human | 1.43493916 |
| 49 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.41963656 |
| 50 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 1.40481557 |
| 51 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.39683449 |
| 52 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.38744674 |
| 53 | EZH2_23942234_ChIP-Seq_MYOBLASTS_AND_MYOTUBES_Mouse | 1.38521404 |
| 54 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.37439434 |
| 55 | P300_19829295_ChIP-Seq_ESCs_Human | 1.37421112 |
| 56 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 1.34220790 |
| 57 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.32956642 |
| 58 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 1.32183156 |
| 59 | * RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.31740987 |
| 60 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.29219332 |
| 61 | AR_25329375_ChIP-Seq_VCAP_Human | 1.29019557 |
| 62 | * P53_22127205_ChIP-Seq_FIBROBLAST_Human | 1.25230581 |
| 63 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.25017179 |
| 64 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.23411068 |
| 65 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.19778911 |
| 66 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.19554738 |
| 67 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.18102681 |
| 68 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.17057018 |
| 69 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.16461983 |
| 70 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.15512530 |
| 71 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.14758591 |
| 72 | ETS2_20176728_ChIP-ChIP_TROPHOBLAST_STEM_CELLS_Mouse | 1.13401031 |
| 73 | * SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.12127541 |
| 74 | GATA3_20176728_ChIP-ChIP_TSCs_Mouse | 1.10940046 |
| 75 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.10202697 |
| 76 | CDX2_20551321_ChIP-Seq_CACO-2_Human | 1.10199564 |
| 77 | * CLOCK_20551151_ChIP-Seq_293T_Human | 1.09119050 |
| 78 | * RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.07636600 |
| 79 | GATA2_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.07429342 |
| 80 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 1.07339463 |
| 81 | SREBP1_19666523_ChIP-Seq_LIVER_Mouse | 1.06050173 |
| 82 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.05605865 |
| 83 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 1.05011605 |
| 84 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.04478871 |
| 85 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.03906092 |
| 86 | * AR_19668381_ChIP-Seq_PC3_Human | 1.03398234 |
| 87 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.03174870 |
| 88 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.01762863 |
| 89 | * SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.00755013 |
| 90 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.00728619 |
| 91 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.00554291 |
| 92 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.00514502 |
| 93 | * STAT3_23295773_ChIP-Seq_U87_Human | 0.99296712 |
| 94 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.98782618 |
| 95 | RCOR2_21632747_ChIP-Seq_MESCs_Mouse | 0.98731414 |
| 96 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.98548102 |
| 97 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.97576573 |
| 98 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.97252801 |
| 99 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 0.96832695 |
| 100 | TP53_16413492_ChIP-PET_HCT116_Human | 0.96379376 |
| 101 | * LXR_22158963_ChIP-Seq_LIVER_Mouse | 0.96302720 |
| 102 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.95929356 |
| 103 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 0.95422326 |
| 104 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 0.94314378 |
| 105 | TCF4_23295773_ChIP-Seq_U87_Human | 0.93866324 |
| 106 | SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.92947104 |
| 107 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 0.92540084 |
| 108 | RCOR3_21632747_ChIP-Seq_MESCs_Mouse | 0.91694665 |
| 109 | FUS_26573619_Chip-Seq_HEK293_Human | 0.89851203 |
| 110 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 0.89336799 |
| 111 | * TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 0.89127489 |
| 112 | CEBPB_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 0.88147860 |
| 113 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.87910004 |
| 114 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 0.87875163 |
| 115 | CBP_20019798_ChIP-Seq_JUKART_Human | 0.87019752 |
| 116 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 0.87019752 |
| 117 | SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.86515889 |
| 118 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 0.86106324 |
| 119 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 0.85197841 |
| 120 | * ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.84607426 |
| 121 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.84231663 |
| 122 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 0.83986527 |
| 123 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.83981164 |
| 124 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.83015868 |
| 125 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.82595465 |
| 126 | * KDM2B_26808549_Chip-Seq_K562_Human | 0.82075487 |
| 127 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.81926550 |
| 128 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.81452869 |
| 129 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 0.81314567 |
| 130 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.81241343 |
| 131 | KLF4_18555785_Chip-Seq_ESCs_Mouse | 0.81177333 |
| 132 | * EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.81090896 |
| 133 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 0.80946246 |
| 134 | * TCF3_18467660_ChIP-ChIP_MESCs_Mouse | 0.80413649 |
| 135 | PU1_27457419_Chip-Seq_LIVER_Mouse | 0.80231249 |
| 136 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.79948004 |
| 137 | * RXR_22108803_ChIP-Seq_LS180_Human | 0.79480644 |
| 138 | MYC_19915707_ChIP-ChIP_AK7_Human | 0.79020249 |
| 139 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 0.77941389 |
| 140 | * FOXA1_21915096_ChIP-Seq_LNCaP-1F5_Human | 0.77247905 |
| 141 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.76942805 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0004859_abnormal_synaptic_plasticity | 5.62792968 |
| 2 | MP0003122_maternal_imprinting | 5.55241579 |
| 3 | MP0003880_abnormal_central_pattern | 4.02293207 |
| 4 | MP0003195_calcinosis | 3.91774517 |
| 5 | MP0003635_abnormal_synaptic_transmissio | 3.70596747 |
| 6 | MP0002822_catalepsy | 3.47580319 |
| 7 | MP0009745_abnormal_behavioral_response | 3.28465611 |
| 8 | MP0003123_paternal_imprinting | 3.24029155 |
| 9 | MP0002064_seizures | 2.89756272 |
| 10 | MP0002063_abnormal_learning/memory/cond | 2.85747470 |
| 11 | MP0009046_muscle_twitch | 2.77212672 |
| 12 | MP0001968_abnormal_touch/_nociception | 2.67576058 |
| 13 | MP0004270_analgesia | 2.59904034 |
| 14 | MP0001501_abnormal_sleep_pattern | 2.52550633 |
| 15 | MP0001486_abnormal_startle_reflex | 2.50981416 |
| 16 | MP0002272_abnormal_nervous_system | 2.47028424 |
| 17 | MP0002572_abnormal_emotion/affect_behav | 2.46891403 |
| 18 | MP0005646_abnormal_pituitary_gland | 2.44100074 |
| 19 | MP0008875_abnormal_xenobiotic_pharmacok | 2.34070769 |
| 20 | MP0005423_abnormal_somatic_nervous | 2.26178626 |
| 21 | MP0005551_abnormal_eye_electrophysiolog | 2.23530387 |
| 22 | MP0003172_abnormal_lysosome_physiology | 2.22248526 |
| 23 | MP0008569_lethality_at_weaning | 2.21203894 |
| 24 | MP0001984_abnormal_olfaction | 2.09077574 |
| 25 | MP0001188_hyperpigmentation | 2.07467776 |
| 26 | MP0000566_synostosis | 2.02877605 |
| 27 | MP0005085_abnormal_gallbladder_physiolo | 1.95356973 |
| 28 | MP0001502_abnormal_circadian_rhythm | 1.91170376 |
| 29 | MP0003879_abnormal_hair_cell | 1.88319309 |
| 30 | MP0005360_urolithiasis | 1.86801133 |
| 31 | MP0003121_genomic_imprinting | 1.84393862 |
| 32 | MP0005365_abnormal_bile_salt | 1.82436312 |
| 33 | MP0002090_abnormal_vision | 1.82371046 |
| 34 | MP0002736_abnormal_nociception_after | 1.79738920 |
| 35 | MP0002139_abnormal_hepatobiliary_system | 1.79107951 |
| 36 | MP0002734_abnormal_mechanical_nocicepti | 1.77770980 |
| 37 | MP0002067_abnormal_sensory_capabilities | 1.73406728 |
| 38 | MP0002909_abnormal_adrenal_gland | 1.62292537 |
| 39 | MP0002089_abnormal_postnatal_growth/wei | 1.62263740 |
| 40 | MP0002557_abnormal_social/conspecific_i | 1.60487259 |
| 41 | MP0000920_abnormal_myelination | 1.56288759 |
| 42 | MP0008872_abnormal_physiological_respon | 1.53480822 |
| 43 | MP0003633_abnormal_nervous_system | 1.52853150 |
| 44 | MP0010329_abnormal_lipoprotein_level | 1.47303991 |
| 45 | MP0008874_decreased_physiological_sensi | 1.47270527 |
| 46 | MP0003075_altered_response_to | 1.47033220 |
| 47 | MP0005386_behavior/neurological_phenoty | 1.45169474 |
| 48 | MP0004924_abnormal_behavior | 1.45169474 |
| 49 | MP0004885_abnormal_endolymph | 1.43311041 |
| 50 | MP0003183_abnormal_peptide_metabolism | 1.41479118 |
| 51 | MP0001915_intracranial_hemorrhage | 1.29194621 |
| 52 | MP0004147_increased_porphyrin_level | 1.28023127 |
| 53 | MP0005535_abnormal_body_temperature | 1.21688096 |
| 54 | MP0001970_abnormal_pain_threshold | 1.19717896 |
| 55 | MP0004811_abnormal_neuron_physiology | 1.19659318 |
| 56 | MP0003868_abnormal_feces_composition | 1.18866733 |
| 57 | MP0010368_abnormal_lymphatic_system | 1.18853271 |
| 58 | MP0009780_abnormal_chondrocyte_physiolo | 1.18049764 |
| 59 | MP0000604_amyloidosis | 1.17309072 |
| 60 | MP0003632_abnormal_nervous_system | 1.16815975 |
| 61 | MP0005058_abnormal_lysosome_morphology | 1.12991214 |
| 62 | MP0001440_abnormal_grooming_behavior | 1.12711086 |
| 63 | MP0002733_abnormal_thermal_nociception | 1.10979574 |
| 64 | MP0000639_abnormal_adrenal_gland | 1.09825174 |
| 65 | MP0005409_darkened_coat_color | 1.08857769 |
| 66 | MP0001905_abnormal_dopamine_level | 1.08428474 |
| 67 | MP0000609_abnormal_liver_physiology | 1.08140629 |
| 68 | MP0004130_abnormal_muscle_cell | 1.07489071 |
| 69 | MP0004142_abnormal_muscle_tone | 1.07110464 |
| 70 | MP0004510_myositis | 1.06113634 |
| 71 | MP0005408_hypopigmentation | 1.04489932 |
| 72 | MP0003631_nervous_system_phenotype | 1.02839660 |
| 73 | MP0002066_abnormal_motor_capabilities/c | 1.02652390 |
| 74 | MP0002184_abnormal_innervation | 1.00864594 |
| 75 | MP0008961_abnormal_basal_metabolism | 1.00594711 |
| 76 | MP0005167_abnormal_blood-brain_barrier | 0.99111468 |
| 77 | MP0002229_neurodegeneration | 0.94952434 |
| 78 | MP0005636_abnormal_mineral_homeostasis | 0.93928426 |
| 79 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.92220219 |
| 80 | MP0003011_delayed_dark_adaptation | 0.90595500 |
| 81 | MP0005670_abnormal_white_adipose | 0.90227270 |
| 82 | MP0002882_abnormal_neuron_morphology | 0.89471617 |
| 83 | MP0005332_abnormal_amino_acid | 0.89174760 |
| 84 | MP0006054_spinal_hemorrhage | 0.88087602 |
| 85 | MP0002069_abnormal_eating/drinking_beha | 0.86737480 |
| 86 | MP0004043_abnormal_pH_regulation | 0.86605278 |
| 87 | MP0002876_abnormal_thyroid_physiology | 0.86590364 |
| 88 | MP0003329_amyloid_beta_deposits | 0.84779597 |
| 89 | MP0006292_abnormal_olfactory_placode | 0.84165877 |
| 90 | MP0004085_abnormal_heartbeat | 0.83228810 |
| 91 | MP0005379_endocrine/exocrine_gland_phen | 0.81850747 |
| 92 | MP0002078_abnormal_glucose_homeostasis | 0.81010994 |
| 93 | MP0002118_abnormal_lipid_homeostasis | 0.80765754 |
| 94 | MP0003690_abnormal_glial_cell | 0.79686559 |
| 95 | MP0004742_abnormal_vestibular_system | 0.79332788 |
| 96 | MP0004215_abnormal_myocardial_fiber | 0.78773236 |
| 97 | MP0002971_abnormal_brown_adipose | 0.78638788 |
| 98 | MP0005084_abnormal_gallbladder_morpholo | 0.77153889 |
| 99 | MP0000955_abnormal_spinal_cord | 0.76493173 |
| 100 | MP0003638_abnormal_response/metabolism_ | 0.76405645 |
| 101 | MP0001664_abnormal_digestion | 0.76241130 |
| 102 | MP0003252_abnormal_bile_duct | 0.75665843 |
| 103 | MP0004036_abnormal_muscle_relaxation | 0.74598658 |
| 104 | MP0000003_abnormal_adipose_tissue | 0.73838424 |
| 105 | MP0001270_distended_abdomen | 0.72829018 |
| 106 | MP0001765_abnormal_ion_homeostasis | 0.72552869 |
| 107 | MP0005464_abnormal_platelet_physiology | 0.72433110 |
| 108 | MP0005448_abnormal_energy_balance | 0.71963641 |
| 109 | MP0002132_abnormal_respiratory_system | 0.71376429 |
| 110 | MP0004019_abnormal_vitamin_homeostasis | 0.71201328 |
| 111 | MP0002735_abnormal_chemical_nociception | 0.71172732 |
| 112 | MP0009840_abnormal_foam_cell | 0.70623268 |
| 113 | MP0001986_abnormal_taste_sensitivity | 0.69924465 |
| 114 | MP0001177_atelectasis | 0.69701928 |
| 115 | MP0003656_abnormal_erythrocyte_physiolo | 0.69562636 |
| 116 | MP0005166_decreased_susceptibility_to | 0.69556778 |
| 117 | MP0001529_abnormal_vocalization | 0.69205972 |
| 118 | MP0005253_abnormal_eye_physiology | 0.68612472 |
| 119 | MP0000631_abnormal_neuroendocrine_gland | 0.68449044 |
| 120 | MP0001756_abnormal_urination | 0.68172655 |
| 121 | MP0001666_abnormal_nutrient_absorption | 0.67317603 |
| 122 | MP0002638_abnormal_pupillary_reflex | 0.67063257 |
| 123 | MP0001764_abnormal_homeostasis | 0.67007437 |
| 124 | MP0000013_abnormal_adipose_tissue | 0.66666676 |
| 125 | MP0003953_abnormal_hormone_level | 0.66371983 |
| 126 | MP0000230_abnormal_systemic_arterial | 0.65534964 |
| 127 | MP0003943_abnormal_hepatobiliary_system | 0.65363520 |
| 128 | MP0005451_abnormal_body_composition | 0.65142866 |
| 129 | MP0005410_abnormal_fertilization | 0.65009565 |
| 130 | MP0004484_altered_response_of | 0.64616065 |
| 131 | MP0002254_reproductive_system_inflammat | 0.63448306 |
| 132 | MP0002160_abnormal_reproductive_system | 0.62127219 |
| 133 | MP0009642_abnormal_blood_homeostasis | 0.61565252 |
| 134 | MP0001963_abnormal_hearing_physiology | 0.61002399 |
| 135 | MP0005174_abnormal_tail_pigmentation | 0.60899388 |
| 136 | MP0000751_myopathy | 0.60711758 |
| 137 | MP0000598_abnormal_liver_morphology | 0.58575626 |
| 138 | MP0003634_abnormal_glial_cell | 0.58183572 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Focal motor seizures (HP:0011153) | 7.28880138 |
| 2 | Complement deficiency (HP:0004431) | 5.64134108 |
| 3 | Joint hemorrhage (HP:0005261) | 5.62718158 |
| 4 | Hypobetalipoproteinemia (HP:0003563) | 5.41384322 |
| 5 | Epileptic encephalopathy (HP:0200134) | 5.31830437 |
| 6 | Myokymia (HP:0002411) | 5.02137363 |
| 7 | Febrile seizures (HP:0002373) | 4.87772900 |
| 8 | Abnormality of the common coagulation pathway (HP:0010990) | 4.78504638 |
| 9 | Congenital stationary night blindness (HP:0007642) | 4.66703737 |
| 10 | Focal seizures (HP:0007359) | 4.53753995 |
| 11 | Visual hallucinations (HP:0002367) | 4.49630696 |
| 12 | Hyperventilation (HP:0002883) | 4.46241822 |
| 13 | Glomerulonephritis (HP:0000099) | 4.15237639 |
| 14 | Abnormality of complement system (HP:0005339) | 3.95469293 |
| 15 | Progressive cerebellar ataxia (HP:0002073) | 3.95068153 |
| 16 | Hypercholesterolemia (HP:0003124) | 3.90369344 |
| 17 | Xanthomatosis (HP:0000991) | 3.88539330 |
| 18 | Absence seizures (HP:0002121) | 3.74260617 |
| 19 | Gaze-evoked nystagmus (HP:0000640) | 3.71241863 |
| 20 | Broad-based gait (HP:0002136) | 3.66584783 |
| 21 | Small epiphyses (HP:0010585) | 3.66132703 |
| 22 | Acanthocytosis (HP:0001927) | 3.57845613 |
| 23 | Poor eye contact (HP:0000817) | 3.51033327 |
| 24 | Systemic lupus erythematosus (HP:0002725) | 3.37996993 |
| 25 | Atonic seizures (HP:0010819) | 3.37596148 |
| 26 | Scanning speech (HP:0002168) | 3.35004749 |
| 27 | Genetic anticipation (HP:0003743) | 3.31912899 |
| 28 | Epidermoid cyst (HP:0200040) | 3.31018897 |
| 29 | Menorrhagia (HP:0000132) | 3.27490868 |
| 30 | Dialeptic seizures (HP:0011146) | 3.26628757 |
| 31 | Abnormal social behavior (HP:0012433) | 3.22457940 |
| 32 | Impaired social interactions (HP:0000735) | 3.22457940 |
| 33 | Anxiety (HP:0000739) | 3.19519936 |
| 34 | Generalized tonic-clonic seizures (HP:0002069) | 3.18390632 |
| 35 | Broad alveolar ridges (HP:0000187) | 3.17288317 |
| 36 | Dysdiadochokinesis (HP:0002075) | 3.15820090 |
| 37 | Dysmetric saccades (HP:0000641) | 3.13626101 |
| 38 | Status epilepticus (HP:0002133) | 3.13595809 |
| 39 | Hypolipoproteinemia (HP:0010981) | 3.11989223 |
| 40 | Hemorrhage of the eye (HP:0011885) | 3.05186104 |
| 41 | Abnormality of carpal bone ossification (HP:0006257) | 3.03100205 |
| 42 | Depression (HP:0000716) | 3.01590799 |
| 43 | Action tremor (HP:0002345) | 2.98804123 |
| 44 | Vascular calcification (HP:0004934) | 2.93699553 |
| 45 | Pancreatic islet-cell hyperplasia (HP:0004510) | 2.85836255 |
| 46 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.85368554 |
| 47 | Annular pancreas (HP:0001734) | 2.81694074 |
| 48 | Postural instability (HP:0002172) | 2.80571186 |
| 49 | Stereotypic behavior (HP:0000733) | 2.74901943 |
| 50 | Focal dystonia (HP:0004373) | 2.74514577 |
| 51 | Fair hair (HP:0002286) | 2.74497210 |
| 52 | Torticollis (HP:0000473) | 2.73846799 |
| 53 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 2.73167765 |
| 54 | Truncal ataxia (HP:0002078) | 2.73056202 |
| 55 | Abnormal tarsal ossification (HP:0008369) | 2.71560919 |
| 56 | Abnormality of macular pigmentation (HP:0008002) | 2.69858959 |
| 57 | Impaired smooth pursuit (HP:0007772) | 2.64848087 |
| 58 | Abnormality of the intrinsic pathway (HP:0010989) | 2.58000375 |
| 59 | Epiphyseal dysplasia (HP:0002656) | 2.57472906 |
| 60 | Impaired vibration sensation in the lower limbs (HP:0002166) | 2.57366553 |
| 61 | Central scotoma (HP:0000603) | 2.57355690 |
| 62 | Craniofacial dystonia (HP:0012179) | 2.56481464 |
| 63 | Hypoglycemic coma (HP:0001325) | 2.53454017 |
| 64 | Alacrima (HP:0000522) | 2.53125704 |
| 65 | Hepatoblastoma (HP:0002884) | 2.51366013 |
| 66 | Abnormality of the periventricular white matter (HP:0002518) | 2.51073366 |
| 67 | Cardiovascular calcification (HP:0011915) | 2.50139688 |
| 68 | Dysmetria (HP:0001310) | 2.49553189 |
| 69 | Conjugated hyperbilirubinemia (HP:0002908) | 2.47954779 |
| 70 | Gingival bleeding (HP:0000225) | 2.46979498 |
| 71 | Generalized hypopigmentation of hair (HP:0011358) | 2.45777615 |
| 72 | Purpura (HP:0000979) | 2.45660008 |
| 73 | Flat acetabular roof (HP:0003180) | 2.43509192 |
| 74 | Mitral stenosis (HP:0001718) | 2.43440534 |
| 75 | Broad palm (HP:0001169) | 2.43299965 |
| 76 | Hemiplegia (HP:0002301) | 2.40913708 |
| 77 | Hyperlipoproteinemia (HP:0010980) | 2.40340308 |
| 78 | Abnormality of the lumbar spine (HP:0100712) | 2.39832529 |
| 79 | Decreased central vision (HP:0007663) | 2.39045067 |
| 80 | Abnormality of the level of lipoprotein cholesterol (HP:0010979) | 2.38610077 |
| 81 | Urinary bladder sphincter dysfunction (HP:0002839) | 2.38315214 |
| 82 | Spontaneous abortion (HP:0005268) | 2.38155854 |
| 83 | Intention tremor (HP:0002080) | 2.36487328 |
| 84 | Asymmetry of the thorax (HP:0001555) | 2.34887664 |
| 85 | Abnormal eating behavior (HP:0100738) | 2.34735117 |
| 86 | Abnormality of ocular smooth pursuit (HP:0000617) | 2.34689752 |
| 87 | Nonprogressive disorder (HP:0003680) | 2.33840620 |
| 88 | Abnormality of the nasal septum (HP:0000419) | 2.32448216 |
| 89 | Papilledema (HP:0001085) | 2.31300925 |
| 90 | Arthropathy (HP:0003040) | 2.29748520 |
| 91 | Progressive inability to walk (HP:0002505) | 2.29421255 |
| 92 | Skin nodule (HP:0200036) | 2.29093234 |
| 93 | Fat malabsorption (HP:0002630) | 2.24249159 |
| 94 | Abnormal hand bone ossification (HP:0010660) | 2.24052928 |
| 95 | Hypophosphatemic rickets (HP:0004912) | 2.23687051 |
| 96 | Bradykinesia (HP:0002067) | 2.23501793 |
| 97 | Neurofibrillary tangles (HP:0002185) | 2.22995090 |
| 98 | Impaired vibratory sensation (HP:0002495) | 2.16472173 |
| 99 | Pigmentary retinal degeneration (HP:0001146) | 2.16424818 |
| 100 | Abnormal ossification of hand bones (HP:0005921) | 2.15170404 |
| 101 | Diastasis recti (HP:0001540) | 2.14560896 |
| 102 | Delayed CNS myelination (HP:0002188) | 2.13908996 |
| 103 | Potter facies (HP:0002009) | 2.13785570 |
| 104 | Facial shape deformation (HP:0011334) | 2.13785570 |
| 105 | Abnormal rod and cone electroretinograms (HP:0008323) | 2.13653735 |
| 106 | Inability to walk (HP:0002540) | 2.13474006 |
| 107 | Ankle clonus (HP:0011448) | 2.12804048 |
| 108 | Hypoplasia of the capital femoral epiphysis (HP:0003090) | 2.09625595 |
| 109 | Hypoglycemic seizures (HP:0002173) | 2.08923305 |
| 110 | Abnormality of the wing of the ilium (HP:0011867) | 2.07213764 |
| 111 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 2.06989665 |
| 112 | Nephritis (HP:0000123) | 2.06696329 |
| 113 | Blue irides (HP:0000635) | 2.06400890 |
| 114 | Excessive salivation (HP:0003781) | 2.05837781 |
| 115 | Drooling (HP:0002307) | 2.05837781 |
| 116 | Agitation (HP:0000713) | 2.04738333 |
| 117 | Protruding tongue (HP:0010808) | 2.04659001 |
| 118 | Prolonged bleeding time (HP:0003010) | 2.00501942 |
| 119 | Flared iliac wings (HP:0002869) | 1.98717119 |
| 120 | Thrombophlebitis (HP:0004418) | 1.98037190 |
| 121 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.95408277 |
| 122 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.95408277 |
| 123 | Gout (HP:0001997) | 1.95405220 |
| 124 | Poikilocytosis (HP:0004447) | 1.95191185 |
| 125 | Epileptiform EEG discharges (HP:0011182) | 1.94427208 |
| 126 | Hyperinsulinemic hypoglycemia (HP:0000825) | 1.94344732 |
| 127 | Impaired pain sensation (HP:0007328) | 1.94078357 |
| 128 | Abnormality of pain sensation (HP:0010832) | 1.94078357 |
| 129 | Ketosis (HP:0001946) | 1.92758430 |
| 130 | Abnormality of saccadic eye movements (HP:0000570) | 1.92530135 |
| 131 | Enlarged kidneys (HP:0000105) | 1.92047819 |
| 132 | Irregular epiphyses (HP:0010582) | 1.90864804 |
| 133 | Decreased lacrimation (HP:0000633) | 1.90635627 |
| 134 | Hemiparesis (HP:0001269) | 1.90430895 |
| 135 | Deep venous thrombosis (HP:0002625) | 1.89382295 |
| 136 | Vaginal fistula (HP:0004320) | 1.87688881 |
| 137 | Bronchomalacia (HP:0002780) | 1.86788972 |
| 138 | Intrahepatic cholestasis (HP:0001406) | 1.84671537 |
| 139 | Psychosis (HP:0000709) | 1.83009753 |
| 140 | Mutism (HP:0002300) | 1.80764921 |
| 141 | Increased serum pyruvate (HP:0003542) | 1.80709848 |
| 142 | Limb ataxia (HP:0002070) | 1.80587323 |
| 143 | Abnormal EKG (HP:0003115) | 1.80534103 |
| 144 | Spinal canal stenosis (HP:0003416) | 1.79973105 |
| 145 | EEG with generalized epileptiform discharges (HP:0011198) | 1.79468570 |
| 146 | Hypothermia (HP:0002045) | 1.78769782 |
| 147 | Supranuclear gaze palsy (HP:0000605) | 1.77205620 |
| 148 | Abnormality of glycolysis (HP:0004366) | 1.76377756 |
| 149 | Generalized myoclonic seizures (HP:0002123) | 1.76068971 |
| 150 | Rickets (HP:0002748) | 1.75400529 |
| 151 | Osteomalacia (HP:0002749) | 1.75141093 |
| 152 | Severe visual impairment (HP:0001141) | 1.74047336 |
| 153 | Abnormality of the heme biosynthetic pathway (HP:0010472) | 1.73951143 |
| 154 | Acute lymphatic leukemia (HP:0006721) | 1.73169461 |
| 155 | Ventricular fibrillation (HP:0001663) | 1.72762196 |
| 156 | Rigidity (HP:0002063) | 1.72321622 |
| 157 | Severe global developmental delay (HP:0011344) | 1.72144031 |
| 158 | Clumsiness (HP:0002312) | 1.69292974 |
| 159 | Amblyopia (HP:0000646) | 1.69026247 |
| 160 | Akinesia (HP:0002304) | 1.68067979 |
| 161 | Cerebral inclusion bodies (HP:0100314) | 1.66414438 |
| 162 | Hypoalphalipoproteinemia (HP:0003233) | 1.66373953 |
| 163 | Prolonged QT interval (HP:0001657) | 1.65487756 |
| 164 | Dyskinesia (HP:0100660) | 1.65432520 |
| 165 | Papillary thyroid carcinoma (HP:0002895) | 1.65308106 |
| 166 | Aplasia/Hypoplasia of the capital femoral epiphysis (HP:0005003) | 1.65236336 |
| 167 | Absent epiphyses (HP:0010577) | 1.65236336 |
| 168 | Prolonged partial thromboplastin time (HP:0003645) | 1.65020294 |
| 169 | Absent speech (HP:0001344) | 1.64777381 |
| 170 | Neonatal onset (HP:0003623) | 1.64193964 |
| 171 | Absent rod-and cone-mediated responses on ERG (HP:0007688) | 1.63846791 |
| 172 | Pulmonary embolism (HP:0002204) | 1.63237335 |
| 173 | Choreoathetosis (HP:0001266) | 1.62048938 |
| 174 | Gait ataxia (HP:0002066) | 1.59239093 |
| 175 | Abnormality of the lower motor neuron (HP:0002366) | 1.58368932 |
| 176 | Cholecystitis (HP:0001082) | 1.55737569 |
| 177 | Abnormal gallbladder physiology (HP:0012438) | 1.55737569 |
| 178 | Diplopia (HP:0000651) | 1.55477720 |
| 179 | Abnormality of binocular vision (HP:0011514) | 1.55477720 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FGFR4 | 4.23993251 |
| 2 | EPHA4 | 4.09467242 |
| 3 | FGFR3 | 4.03178844 |
| 4 | NTRK3 | 3.15180491 |
| 5 | CDK19 | 3.12244992 |
| 6 | TNIK | 3.10322404 |
| 7 | MAP3K4 | 2.94441420 |
| 8 | MAP2K7 | 2.90494317 |
| 9 | MAP3K9 | 2.83370492 |
| 10 | WNK4 | 2.78516953 |
| 11 | MAP3K12 | 2.46799052 |
| 12 | DAPK2 | 2.44455403 |
| 13 | TYRO3 | 2.42878924 |
| 14 | FGFR2 | 2.41659250 |
| 15 | MAP2K4 | 2.37878550 |
| 16 | ICK | 2.24822408 |
| 17 | CAMKK1 | 2.14861955 |
| 18 | PIK3CA | 2.11663002 |
| 19 | AKT3 | 1.96400626 |
| 20 | CASK | 1.96095738 |
| 21 | WNK1 | 1.94805211 |
| 22 | CDK12 | 1.90114584 |
| 23 | DAPK1 | 1.87953895 |
| 24 | CAMKK2 | 1.87819378 |
| 25 | MUSK | 1.85534217 |
| 26 | LATS1 | 1.84319279 |
| 27 | MINK1 | 1.82265754 |
| 28 | RIPK4 | 1.80499309 |
| 29 | LATS2 | 1.79973662 |
| 30 | SGK2 | 1.79802011 |
| 31 | TNK2 | 1.78694549 |
| 32 | KIT | 1.73786196 |
| 33 | FES | 1.61794397 |
| 34 | CAMK1 | 1.55138098 |
| 35 | PINK1 | 1.54514218 |
| 36 | FGFR1 | 1.50435424 |
| 37 | MAP3K13 | 1.45424538 |
| 38 | SGK3 | 1.42807351 |
| 39 | SGK223 | 1.42171968 |
| 40 | SGK494 | 1.42171968 |
| 41 | MAP2K3 | 1.40693987 |
| 42 | STK38 | 1.38899490 |
| 43 | CCNB1 | 1.34830389 |
| 44 | PDGFRA | 1.32246259 |
| 45 | PRKD3 | 1.26674767 |
| 46 | NTRK2 | 1.23569485 |
| 47 | TIE1 | 1.21314300 |
| 48 | KSR2 | 1.20974087 |
| 49 | MAPKAPK5 | 1.19708847 |
| 50 | TAOK1 | 1.14372477 |
| 51 | PAK6 | 1.14359968 |
| 52 | CDK5 | 1.13082549 |
| 53 | PDK1 | 1.10402087 |
| 54 | OXSR1 | 1.07078463 |
| 55 | MAP3K7 | 1.06816394 |
| 56 | PRKAA2 | 1.02000828 |
| 57 | PRKCH | 0.97895951 |
| 58 | SIK2 | 0.97438472 |
| 59 | PRPF4B | 0.94176370 |
| 60 | RPS6KB1 | 0.89171563 |
| 61 | MAP2K6 | 0.88104967 |
| 62 | RIPK1 | 0.87821859 |
| 63 | RET | 0.87312118 |
| 64 | GRK5 | 0.84148009 |
| 65 | MAP3K6 | 0.81641394 |
| 66 | CAMK4 | 0.81450083 |
| 67 | PRKD2 | 0.80775803 |
| 68 | EEF2K | 0.80573428 |
| 69 | BCKDK | 0.80496533 |
| 70 | FLT3 | 0.80369696 |
| 71 | PRKCG | 0.77949376 |
| 72 | MATK | 0.75831158 |
| 73 | CSNK1E | 0.74688316 |
| 74 | STK39 | 0.74647305 |
| 75 | STK11 | 0.74386907 |
| 76 | NTRK1 | 0.72841719 |
| 77 | ALK | 0.72828112 |
| 78 | MAP3K1 | 0.72504610 |
| 79 | PDPK1 | 0.72232112 |
| 80 | MAP3K2 | 0.69603022 |
| 81 | MAPK11 | 0.67617635 |
| 82 | CAMK1G | 0.66137779 |
| 83 | SIK3 | 0.65898788 |
| 84 | MAPK10 | 0.65642166 |
| 85 | CAMK2A | 0.64628442 |
| 86 | MAPK13 | 0.64468712 |
| 87 | BRSK1 | 0.62595857 |
| 88 | MAPK12 | 0.62472049 |
| 89 | NEK6 | 0.62350629 |
| 90 | DYRK1B | 0.60404961 |
| 91 | SGK1 | 0.60047165 |
| 92 | HIPK2 | 0.58296335 |
| 93 | KSR1 | 0.58231252 |
| 94 | ERBB2 | 0.58189563 |
| 95 | CDK15 | 0.57657326 |
| 96 | ERN1 | 0.56642684 |
| 97 | ARAF | 0.56407029 |
| 98 | PRKCZ | 0.55798451 |
| 99 | MARK1 | 0.55674545 |
| 100 | DDR2 | 0.55151148 |
| 101 | DYRK1A | 0.54872603 |
| 102 | BMPR2 | 0.54512904 |
| 103 | TAOK2 | 0.53473549 |
| 104 | MAPK7 | 0.53384310 |
| 105 | RAF1 | 0.52784354 |
| 106 | PRKAA1 | 0.52415444 |
| 107 | SYK | 0.52263497 |
| 108 | MAPKAPK3 | 0.50901190 |
| 109 | PKN2 | 0.50397444 |
| 110 | ADRBK2 | 0.49946420 |
| 111 | RPS6KA3 | 0.45910750 |
| 112 | PRKG1 | 0.45755647 |
| 113 | CSNK1D | 0.45464624 |
| 114 | PTK2B | 0.43976059 |
| 115 | PLK2 | 0.43794488 |
| 116 | MAP3K5 | 0.43439710 |
| 117 | MARK2 | 0.42645373 |
| 118 | PRKACG | 0.42116260 |
| 119 | MYLK | 0.41447274 |
| 120 | TGFBR1 | 0.41347316 |
| 121 | CAMK1D | 0.40320490 |
| 122 | SRC | 0.39872392 |
| 123 | PRKG2 | 0.39160420 |
| 124 | CSF1R | 0.38736266 |
| 125 | CDK14 | 0.38335714 |
| 126 | MAPK4 | 0.37950430 |
| 127 | TGFBR2 | 0.37099894 |
| 128 | INSRR | 0.37014401 |
| 129 | CDK3 | 0.36746434 |
| 130 | TXK | 0.34955532 |
| 131 | TRIB3 | 0.34683038 |
| 132 | UHMK1 | 0.34158756 |
| 133 | FYN | 0.33850459 |
| 134 | PRKCB | 0.33684043 |
| 135 | CDK18 | 0.33479582 |
| 136 | PHKG2 | 0.33438265 |
| 137 | PHKG1 | 0.33438265 |
| 138 | CAMK2D | 0.32910851 |
| 139 | CAMK2B | 0.32804198 |
| 140 | CDK11A | 0.32584502 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 4.43126801 |
| 2 | Nitrogen metabolism_Homo sapiens_hsa00910 | 3.58359199 |
| 3 | Nicotine addiction_Homo sapiens_hsa05033 | 3.32176845 |
| 4 | Olfactory transduction_Homo sapiens_hsa04740 | 2.69949915 |
| 5 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 2.69244458 |
| 6 | GABAergic synapse_Homo sapiens_hsa04727 | 2.65098802 |
| 7 | Circadian entrainment_Homo sapiens_hsa04713 | 2.56410824 |
| 8 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 2.46404984 |
| 9 | Morphine addiction_Homo sapiens_hsa05032 | 2.34969880 |
| 10 | Glutamatergic synapse_Homo sapiens_hsa04724 | 2.32049751 |
| 11 | Histidine metabolism_Homo sapiens_hsa00340 | 2.12223180 |
| 12 | Long-term potentiation_Homo sapiens_hsa04720 | 2.07508490 |
| 13 | Salivary secretion_Homo sapiens_hsa04970 | 2.03506237 |
| 14 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 1.97257412 |
| 15 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.91451344 |
| 16 | Fat digestion and absorption_Homo sapiens_hsa04975 | 1.90507057 |
| 17 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.81501178 |
| 18 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.77707600 |
| 19 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.74327366 |
| 20 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 1.73914174 |
| 21 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.70420685 |
| 22 | Insulin secretion_Homo sapiens_hsa04911 | 1.70185261 |
| 23 | Arginine biosynthesis_Homo sapiens_hsa00220 | 1.64840086 |
| 24 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.62957881 |
| 25 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 1.61208704 |
| 26 | Renin secretion_Homo sapiens_hsa04924 | 1.60808739 |
| 27 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.58477468 |
| 28 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.56184472 |
| 29 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.55176766 |
| 30 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.54660484 |
| 31 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 1.48841257 |
| 32 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.47037071 |
| 33 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.44322138 |
| 34 | Phototransduction_Homo sapiens_hsa04744 | 1.40468998 |
| 35 | Taste transduction_Homo sapiens_hsa04742 | 1.33318355 |
| 36 | Tyrosine metabolism_Homo sapiens_hsa00350 | 1.29158365 |
| 37 | Long-term depression_Homo sapiens_hsa04730 | 1.28202047 |
| 38 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 1.27206258 |
| 39 | Circadian rhythm_Homo sapiens_hsa04710 | 1.25725026 |
| 40 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.24813542 |
| 41 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.24010808 |
| 42 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 1.23934871 |
| 43 | GnRH signaling pathway_Homo sapiens_hsa04912 | 1.20479743 |
| 44 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 1.19094412 |
| 45 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.18064946 |
| 46 | Bile secretion_Homo sapiens_hsa04976 | 1.16063055 |
| 47 | Cocaine addiction_Homo sapiens_hsa05030 | 1.12516012 |
| 48 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.09972452 |
| 49 | Retinol metabolism_Homo sapiens_hsa00830 | 1.09192381 |
| 50 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 1.08939657 |
| 51 | Steroid biosynthesis_Homo sapiens_hsa00100 | 1.08141034 |
| 52 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.07281648 |
| 53 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.06319607 |
| 54 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.05950747 |
| 55 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 1.05076148 |
| 56 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 1.03254831 |
| 57 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 0.98435670 |
| 58 | Prion diseases_Homo sapiens_hsa05020 | 0.95533597 |
| 59 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.94028778 |
| 60 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.91494044 |
| 61 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.90536224 |
| 62 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 0.88578192 |
| 63 | Gap junction_Homo sapiens_hsa04540 | 0.86057489 |
| 64 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.81995358 |
| 65 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.81021188 |
| 66 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.80926255 |
| 67 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.75904392 |
| 68 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.75055319 |
| 69 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.74053531 |
| 70 | Caffeine metabolism_Homo sapiens_hsa00232 | 0.72879495 |
| 71 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.72279560 |
| 72 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.72259846 |
| 73 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 0.71422023 |
| 74 | Mineral absorption_Homo sapiens_hsa04978 | 0.67502743 |
| 75 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.66648080 |
| 76 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.66114484 |
| 77 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 0.64855472 |
| 78 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.63988557 |
| 79 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.61926938 |
| 80 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.61350875 |
| 81 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.60212064 |
| 82 | Carbohydrate digestion and absorption_Homo sapiens_hsa04973 | 0.59356194 |
| 83 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.58624209 |
| 84 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.58046102 |
| 85 | Other glycan degradation_Homo sapiens_hsa00511 | 0.57455457 |
| 86 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.56713096 |
| 87 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.56399748 |
| 88 | Glioma_Homo sapiens_hsa05214 | 0.56098457 |
| 89 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.55502594 |
| 90 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.55347735 |
| 91 | Melanogenesis_Homo sapiens_hsa04916 | 0.55058304 |
| 92 | Platelet activation_Homo sapiens_hsa04611 | 0.54659677 |
| 93 | Cyanoamino acid metabolism_Homo sapiens_hsa00460 | 0.53515689 |
| 94 | Insulin resistance_Homo sapiens_hsa04931 | 0.51219568 |
| 95 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.50734196 |
| 96 | Pantothenate and CoA biosynthesis_Homo sapiens_hsa00770 | 0.49794110 |
| 97 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.49359885 |
| 98 | ABC transporters_Homo sapiens_hsa02010 | 0.49142852 |
| 99 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.49028746 |
| 100 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.48786749 |
| 101 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.48650301 |
| 102 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.48647658 |
| 103 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.48235444 |
| 104 | Peroxisome_Homo sapiens_hsa04146 | 0.46456406 |
| 105 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.45831834 |
| 106 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.45821425 |
| 107 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.45819384 |
| 108 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 0.44567869 |
| 109 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.44030294 |
| 110 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.42000962 |
| 111 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.41292270 |
| 112 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.41271315 |
| 113 | Lysine degradation_Homo sapiens_hsa00310 | 0.41171903 |
| 114 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.40249805 |
| 115 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.40164960 |
| 116 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.40157811 |
| 117 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.40126692 |
| 118 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.39454888 |
| 119 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.39209139 |
| 120 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.39122957 |
| 121 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.38508959 |
| 122 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38225053 |
| 123 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.37837299 |
| 124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37606200 |
| 125 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.37495475 |
| 126 | Carbon metabolism_Homo sapiens_hsa01200 | 0.37494638 |
| 127 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 0.37399887 |
| 128 | Galactose metabolism_Homo sapiens_hsa00052 | 0.36106093 |
| 129 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.36076125 |
| 130 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.35626000 |
| 131 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.35180886 |
| 132 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.34675299 |

